Rapid Medical Diagnostics Market Analysis 2025: Outlook in GCC and MENA, Led by North America 38% Share | Meridian Bioscience Inc., OraSure Technologies Inc., Thermo Fisher Scientific Inc., Becton Dickinson and Co

DataM Intelligence has published a new research report on "Rapid Medical Diagnostics Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.

Get Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/rapid-medical-diagnostics-market?kb

United States: Recent Industry Developments

✅ November 2025: Abbott expanded its rapid diagnostic test portfolio for infectious diseases with faster turnaround times.

✅ October 2025: BD introduced next-generation point-of-care diagnostic kits integrated with digital reporting platforms.

✅ September 2025: Increased adoption of rapid diagnostics in emergency care settings improved early disease detection and patient triage.

Japan: Recent Industry Developments

✅ November 2025: Sysmex Corporation advanced rapid diagnostic solutions for hematology and infectious disease screening.

✅ October 2025: Fujifilm Healthcare launched compact rapid testing devices for clinics and remote healthcare facilities.

✅ September 2025: Government-supported initiatives accelerated the use of rapid diagnostics in preventive healthcare programs.

GCC: Recent Industry Developments

✅ November 2025: Saudi Arabia expanded the use of rapid diagnostic kits in public hospitals under healthcare digitalization initiatives.

✅ October 2025: UAE-based healthcare providers adopted rapid diagnostics for chronic disease monitoring and emergency response.

✅ September 2025: Regional collaborations strengthened local manufacturing and distribution of rapid diagnostic testing solutions.

Key Players:

Abbot Laboratories, Bio-Rad Laboratories, AccessBio Inc., AccuBioTech Co. Ltd., Quidel Corporation, Meridian Bioscience Inc., OraSure Technologies Inc., Thermo Fisher Scientific Inc., Becton Dickinson and Co., Trinity Biotech Plc.

Key Industry Development:

Technology and test menu trends

1. Infectious‐disease rapid tests (for COVID‐19, influenza, RSV, HIV, malaria, TB and others) remain core revenue drivers, with strong interest in multiplex assays that detect multiple pathogens from a single sample.​

2. 2025 analyses highlight rapid growth in point‐of‐care molecular diagnostics, projected from about USD 4.5 billion in 2025 to roughly USD 11 billion by 2034, as cartridge‐based NAATs move closer to bedside and retail pharmacies.​

3. There is continued expansion of rapid tests for cardiometabolic risk (lipids, HbA1c), cardiac markers, pregnancy/fertility and drugs of abuse, often designed for use in clinics, ambulances, and home settings.​

Digital, AI and at‐home testing

1. AI and machine‐learning models are being embedded into readers and cloud platforms to interpret faint lines, quantify analytes, reduce user error and offer decision support, especially for image‐based lateral‐flow tests.​

2. Smartphone‐integrated tests and connected readers are enabling home‐based sample collection with app‐based guidance, automatic result capture, and secure transmission to EHRs for remote monitoring and telehealth workflows.​

3. OTC/DTC infectious‐disease diagnostics reports in 2025 point to rapid growth in self‐testing channels, with next‐gen sampling (e.g., saliva, minimally invasive blood) and digitally verified results supporting public‐health surveillance.

Growth Forecast Projected:

The Global Rapid Medical Diagnostics Market is anticipated to rise at a considerable rate during the forecast period, between 2025 and 2032. In 2024, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

Research Process:

Both primary and secondary data sources have been used in the global Rapid Medical Diagnostics Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Buy Now & Get 30% OFF - Grab 50% OFF on 2+ reports: https://www.datamintelligence.com/buy-now-page?report=rapid-medical-diagnostics-market?kb

Key Segments:

By Technology: (Lateral Flow Immunoassays, Lateral Flow Immunoassays, Solid Phase Assays, Agglutination Assays, Microfluidic Chips)

By Type: (Infectious Diseases, Toxicology, Cardiovascular and Gastrointestinal disorders)

By End-Users: (Hospitals, Clinics, Self-Care)

Regional Analysis for Rapid Medical Diagnostics Market:

⇥ United States / North America: 38% market in 2025.

⇥ Europe: 27.5% market in 2025.

⇥ Asia-Pacific (including Japan & South Korea): 23.8% market in 2025.

⇥ Japan: Constitutes 22.7% market in 2025.

⇥ South Korea: Represents 9.8% market in 2025.

Benefits of the Report:

Chapter 1: Lays the foundation by defining the scope of the report, highlighting core market segments across regions, product types, and applications. It delivers a clear snapshot of current market size, growth potential, and how the industry is expected to evolve in both the near and long term.

Chapter 2: Spotlights the most impactful market insights, unveiling the transformative trends and forces shaping the future of the industry.

Chapter 3: Provides a deep dive into the competitive landscape of , covering revenue shares, strategic initiatives, and notable mergers & acquisitions that are reshaping the market.

Chapter 4: Presents detailed company profiles of leading players featuring financial performance, product portfolios, profit margins, and key milestones that set them apart in the industry.

Chapters 5 & 6: Break down revenue analysis at both regional and country levels, offering precise data on market size, growth drivers, and expansion opportunities across global markets.

Chapter 7: Analyzes the market by product type, spotlighting segment-specific opportunities and helping stakeholders identify untapped, high-growth areas.

Chapter 8: Explores the market through application-based segmentation, assessing demand across industries and pinpointing downstream sectors with the strongest potential for growth.

Chapter 9: Maps the industry's supply chain in detail, tracing upstream and downstream activities to provide clarity on value creation across the ecosystem.

Chapter 10: Wraps up with a concise summary of the report's key insights distilling the most critical findings and strategic takeaways for decision-makers and stakeholders.

Get Customization in the report as per your requirements: https://datamintelligence.com/customize/rapid-medical-diagnostics-market?kb

Regulatory and policy developments

1. Regulators continue to refine emergency and accelerated pathways for rapid POC tests; by mid‐2025, over a thousand designations had been granted for innovative POC diagnostics, streamlining market entry while maintaining quality requirements.​

2. Updated guidance for SARS‐CoV‐2 rapid testing in point‐of‐care settings in 2025 reiterates CLIA, quality‐control and reporting obligations, signaling that strengthened regulatory oversight of rapid tests will persist beyond the pandemic phase.​

Notable FDA activity

Recent FDA actions underscore the push to decentralize infectious‐disease diagnosis, for example authorizing the first point‐of‐care HCV RNA test in 2024, which enables test‐and‐treat workflows in community and outpatient settings and sets a template for future rapid molecular approvals.

Unlock Free 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.